Cargando…

23 Chlorhexidine Delays Wound Healing in Human Skin

INTRODUCTION: Chlorhexidine (CHG) is ubiquitous in surgical perioperative care. In vivo studies of CHG cytotoxicity on human skin are lacking. Given the use of CHG for daily wound cares and as a presurgical scrub, including donor site preparation, we sought to identify if CHG cytotoxicity would pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, Angela, Liu, Aiping, Tran, Collin L, Hassan, Sameeha E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945755/
http://dx.doi.org/10.1093/jbcr/irac012.026
_version_ 1784674029156696064
author Gibson, Angela
Liu, Aiping
Tran, Collin L
Hassan, Sameeha E
author_facet Gibson, Angela
Liu, Aiping
Tran, Collin L
Hassan, Sameeha E
author_sort Gibson, Angela
collection PubMed
description INTRODUCTION: Chlorhexidine (CHG) is ubiquitous in surgical perioperative care. In vivo studies of CHG cytotoxicity on human skin are lacking. Given the use of CHG for daily wound cares and as a presurgical scrub, including donor site preparation, we sought to identify if CHG cytotoxicity would persist in a clinically relevant in vivo human skin xenograft model. METHODS: Human skin tissues were obtained from elective surgeries. Partial thickness wounds were created ex vivo in human skin using a 4 mm punch biopsy. 2% CHG (treatment) or PBS (control) was applied to the wounds for 30 minutes followed by rinsing the tissue +/- mechanical disruptive irrigation. Tissues were cultured at the air-liquid interface for 24 hours in culture media after treatment and tissue viability was performed using an MTT assay. For in vivo studies, athymic mice (n=4) were grafted on bilateral flanks with human skin. Eight weeks after engraftment and normalization of skin architecture, 4 mm partial thickness wounds were created on each xenograft (2 per mouse – treatment and control). 2% CHG was applied daily for 2 minutes followed by irrigation with PBS in the treatment wound. The control wound received PBS application and irrigation. The xenografts received treatment daily for 14 days to mimic daily wound cares, and digital images were obtained to document presence of infection and gross wound healing. On day 14, the xenografts were harvested and stained for lactate dehydrogenase and H&E to assess cell viability and wound re-epithelization, respectively. RESULTS: An MTT assay on ex vivo human skin wounds showed that CHG treated groups (irrigation or non-irrigation) had lower cell viability compared to the PBS treated group, however irrigation mitigates the cytotoxicity of CHG on human skin. In the in vivo xenograft study, no signs of infection were identified in either PBS or CHG treated wounds throughout the study. The wound size appeared larger on gross inspection in the CHG treated group compared to the PBS group as early as day 2.Microscopically, the PBS treated wounds were fully re-epithelialized (n=2) or had significantly more re-epithelialization (n=2) than the CHG treated wounds (n=4) after 14 days of treatment. The PBS-treated wounds were viable throughout the tissue, indicating the irrigation procedure was not harmful to the cells. In the CHG-treated wounds, nonviable cells were observed in the dermis beneath the wound that was directly in contact with CHG suggesting penetration of CHG contributes to cytotoxicity in acute wounds. CONCLUSIONS: Daily CHG use is cytotoxic to human skin and impedes wound healing.
format Online
Article
Text
id pubmed-8945755
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89457552022-03-28 23 Chlorhexidine Delays Wound Healing in Human Skin Gibson, Angela Liu, Aiping Tran, Collin L Hassan, Sameeha E J Burn Care Res Correlative III: Translational Sciences: Wounds & Scars INTRODUCTION: Chlorhexidine (CHG) is ubiquitous in surgical perioperative care. In vivo studies of CHG cytotoxicity on human skin are lacking. Given the use of CHG for daily wound cares and as a presurgical scrub, including donor site preparation, we sought to identify if CHG cytotoxicity would persist in a clinically relevant in vivo human skin xenograft model. METHODS: Human skin tissues were obtained from elective surgeries. Partial thickness wounds were created ex vivo in human skin using a 4 mm punch biopsy. 2% CHG (treatment) or PBS (control) was applied to the wounds for 30 minutes followed by rinsing the tissue +/- mechanical disruptive irrigation. Tissues were cultured at the air-liquid interface for 24 hours in culture media after treatment and tissue viability was performed using an MTT assay. For in vivo studies, athymic mice (n=4) were grafted on bilateral flanks with human skin. Eight weeks after engraftment and normalization of skin architecture, 4 mm partial thickness wounds were created on each xenograft (2 per mouse – treatment and control). 2% CHG was applied daily for 2 minutes followed by irrigation with PBS in the treatment wound. The control wound received PBS application and irrigation. The xenografts received treatment daily for 14 days to mimic daily wound cares, and digital images were obtained to document presence of infection and gross wound healing. On day 14, the xenografts were harvested and stained for lactate dehydrogenase and H&E to assess cell viability and wound re-epithelization, respectively. RESULTS: An MTT assay on ex vivo human skin wounds showed that CHG treated groups (irrigation or non-irrigation) had lower cell viability compared to the PBS treated group, however irrigation mitigates the cytotoxicity of CHG on human skin. In the in vivo xenograft study, no signs of infection were identified in either PBS or CHG treated wounds throughout the study. The wound size appeared larger on gross inspection in the CHG treated group compared to the PBS group as early as day 2.Microscopically, the PBS treated wounds were fully re-epithelialized (n=2) or had significantly more re-epithelialization (n=2) than the CHG treated wounds (n=4) after 14 days of treatment. The PBS-treated wounds were viable throughout the tissue, indicating the irrigation procedure was not harmful to the cells. In the CHG-treated wounds, nonviable cells were observed in the dermis beneath the wound that was directly in contact with CHG suggesting penetration of CHG contributes to cytotoxicity in acute wounds. CONCLUSIONS: Daily CHG use is cytotoxic to human skin and impedes wound healing. Oxford University Press 2022-03-23 /pmc/articles/PMC8945755/ http://dx.doi.org/10.1093/jbcr/irac012.026 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Burn Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correlative III: Translational Sciences: Wounds & Scars
Gibson, Angela
Liu, Aiping
Tran, Collin L
Hassan, Sameeha E
23 Chlorhexidine Delays Wound Healing in Human Skin
title 23 Chlorhexidine Delays Wound Healing in Human Skin
title_full 23 Chlorhexidine Delays Wound Healing in Human Skin
title_fullStr 23 Chlorhexidine Delays Wound Healing in Human Skin
title_full_unstemmed 23 Chlorhexidine Delays Wound Healing in Human Skin
title_short 23 Chlorhexidine Delays Wound Healing in Human Skin
title_sort 23 chlorhexidine delays wound healing in human skin
topic Correlative III: Translational Sciences: Wounds & Scars
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945755/
http://dx.doi.org/10.1093/jbcr/irac012.026
work_keys_str_mv AT gibsonangela 23chlorhexidinedelayswoundhealinginhumanskin
AT liuaiping 23chlorhexidinedelayswoundhealinginhumanskin
AT trancollinl 23chlorhexidinedelayswoundhealinginhumanskin
AT hassansameehae 23chlorhexidinedelayswoundhealinginhumanskin